Artículos por temáticas
En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.
Tema
Tics y síndrome de Tourette
94 ARTíCULOS , VIENDO DEL 1 AL 15
Aripiprazole Therapy and CYP2D6 Genotype
Dean L, Kane M.
2016 Sep 22 [updated 2021 Feb 10]. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kane MS, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
0
0
0
Atomoxetine Therapy and CYP2D6 Genotype
Dean L.
2015 Sep 10 [updated 2020 Jun 29]. In: Pratt VM, McLeod HL, Rubinstein WS, Scott SA, Dean LC, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
0
0
0
McCairn KW, Iriki A, Isoda M.
Neuroreport. 2012 Mar 7;23(4):206-10. doi: 10.1097/WNR.0b013e32834fab9d.
0
0
0
Treatment practices in Tourette syndrome: the European perspective.
Rickards H, Cavanna AE, Worrall R.
Eur J Paediatr Neurol. 2012 Jul;16(4):361-4. doi: 10.1016/j.ejpn.2011.12.001.
0
0
0
Pind R.
Ugeskr Laeger. 2012 Apr 16;174(16):1108; author reply 1108. Danish. No abstract available.
0
0
0
Karagiannidis I, Rizzo R, Tarnok Z, Wolanczyk T, Hebebrand J, Nöthen MM, Lehmkuhl G, Farkas L, Nagy P, Barta C, Szymanska U, Panteloglou G, Miranda DM, Feng Y, Sandor P, Barr C; TSGeneSEE., Paschou P.
Mol Psychiatry. 2012 Jul;17(7):665-8. doi: 10.1038/mp.2011.151. No abstract available.
0
0
0
Motor-cortical interaction in Gilles de la Tourette syndrome.
Franzkowiak S, Pollok B, Biermann-Ruben K, Südmeyer M, Paszek J, Thomalla G, Jonas M, Orth M, Münchau A, Schnitzler A.
PLoS One. 2012;7(1):e27850. doi: 10.1371/journal.pone.0027850.
0
0
0
Amiri S, Fakhari A, Golmirzaei J, Mohammadpoorasl A, Abdi S.
Arch Iran Med. 2012 Feb;15(2):76-8. doi: 012152/AIM.004.
0
0
0
Deep brain stimulation for treatment of refractory Tourette syndrome: long-term follow-up.
Porta M, Servello D, Zanaboni C, Anasetti F, Menghetti C, Sassi M, Robertson MM.
Acta Neurochir (Wien). 2012 Nov;154(11):2029-41. doi: 10.1007/s00701-012-1497-8.
0
0
0
The prognosis of Tourette syndrome: implications for clinical practice.
Hassan N, Cavanna AE.
Funct Neurol. 2012 Jan-Mar;27(1):23-7. Review.
0
0
0
Executive functions in uncomplicated Tourette syndrome.
Eddy CM, Rickards HE, Cavanna AE.
Psychiatry Res. 2012 Nov 30;200(1):46-8. doi: 10.1016/j.psychres.2012.05.023.
0
0
0
The pathophysiology of echopraxia/echolalia: relevance to Gilles de la Tourette syndrome.
Ganos C, Ogrzal T, Schnitzler A, Münchau A.
Mov Disord. 2012 Sep 1;27(10):1222-9. doi: 10.1002/mds.25103. Review.
0
0
0
Atomoxetine-induced vocal tics in a patient with schizophrenia.
Raveendranathan D, Rao MG, Varambally S, Venkatasubramanian G, Gangadhar BN.
J Neuropsychiatry Clin Neurosci. 2012 Fall;24(4):E45-6. doi: 10.1176/appi.neuropsych.11110333. No abstract available.
0
0
0
From ipse dixit to evidence-based guidelines: on the optimal management of Tourette syndrome.
Cavanna AE, Rickards H, Worrall R, Hoekstra PJ, Plessen KJ, Roessner V.
Eur J Paediatr Neurol. 2012 May;16(3):310-1. doi: 10.1016/j.ejpn.2012.01.010. No abstract available.
0
0
0
The most cited works in Tourette syndrome.
Mariam N, Cavanna AE.
J Child Neurol. 2012 Oct;27(10):1250-9.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
